The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.

NCT05788133 | Completed

• 1 other identifier: TRAIT2021
• Study Type: interventional
• Target: 65
• Locations: 1 country
• Sites: 1

Brief Summary

The role of humanoid robot in neuropsychological assessment and conducting cognitive training in patients with dementia and severe brain injury" Objectives Use of robotic solutions to carry out diagnostic and rehabilitation intervention in order to recover cognitive and relational performance of patients with dementia and severe brain injury. Study Design. Observational Materials and Methods. Eighty subjects (25 with mild-moderate dementia and 25 patients with severe brain injury) will be enrolled. Patients will undergo neurological examination with collection of all medical history and information on current clinical condition. After that, they will undergo administration of neuropsychological tests via humanoid robot and two months of cognitive rehabilitation sessions. Inclusion criteria

• Over 18 years of age;
• Patients with a moderately impaired cognitive profile;
• Written consent from the legal guardian or the patient himself/herself. Exclusion criteria.
• Patients with language comprehension deficits;
• Patients with disorders of consciousness;
• Patients who are unable to provide a localized, context-appropriate response; and All eligible patients will undergo cognitive assessment using the robot at the time of enrollment (T0), and after 2 months of rehabilitation treatment (T1) Translated with www.DeepL.com/Translator (free version)

Conditions

Neurodegenerative Diseases; Stroke

Outcome Measures

Primary Outcomes (1)

• mini mental state examination (MMSE)

  administration MMSE with humanoid robot

  2 months

Study Arms (1)

treatment

EXPERIMENTAL

administration neuropsychological tests with pepper

Other: treatment and screening by neuropsychological tests on humanoid robot

Interventions

treatment and screening by neuropsychological tests on humanoid robot OTHER

treatment and screening by neuropsychological tests on humanoid robot

treatment

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Over 18 years old;
• Patients with moderately impaired cognitive profile;
• Written consent from the legal guardian or the patient himself

You may not qualify if:

• Patients with language comprehension deficit;
• Patients with disorders of consciousness;
• Patients who are unable to provide a localized and context-appropriate response

Sponsors & Collaborators

• IRCCS Centro Neurolesi Bonino Pulejo: lead

Study Sites (1)

IRCCS Centro Neurolesi "Bonino-Pulejo"

Messina, 98124, Italy

Location

MeSH Terms

Conditions

Neurodegenerative Diseases; Stroke

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Nervous System Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• silvia marino, MD

  IRCCS Centro Neurolesi Bonino Pulejo

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Neurologist

Study Record Dates

• First Submitted: March 14, 2023
• First Posted: March 28, 2023
• Study Start: September 28, 2022
• Primary Completion: December 31, 2022
• Study Completion: December 31, 2022
• Last Updated: March 28, 2023

Record last verified: 2022-09

Data Sharing

• IPD Sharing: Will not share

Locations

IT (1)